NCT06673953 Effect of Respiratory Trainer on Cardiopulmonary Functions in Patients with Upper Cross Syndrome Post-Cardiac Surgery
| NCT ID | NCT06673953 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Post Coronary Artery Bypass Grafting |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-08-28 |
| Primary Completion | 2025-01-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2024-08-28 with a primary completion date of 2025-01-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to investigate if there is any effect of the respiratory training on cardiopulmonary functions in patients with upper cross syndrome post-cardiac surgery. Hypothesis: Null hypothesis: There is no effect of the respiratory training on pulmonary functions in patients with upper cross syndrome post-cardiac surgery.
Eligibility Criteria
Inclusion Criteria: * Sixty post-CABG-male-patients for at least three months and their age ranges from 45 to 55 years old. * Craniovertebral angle \< 51°, but not less than 30°. * Non-specific chronic neck pain: defined as neck pain without an identifiable pathological cause and attributed to poor posture without radiation to upper limbs. * VAS score between 3-7. * Their body mass index ranges from (25 -29.9) kg/m2. * Values of FEV1 and FVC lower than 80% Exclusion Criteria: * Rheumatoid arthritis, cervical disc pathology, and traumatic neck pain. * History of respiratory disease and clinical signs of severe cardiac events. * Neurological disorders which affect the diaphragm. * Patients whose BMI is less than 25, or greater than 30 kg/m2. * Smokers. * Values of FEV1 and FVC higher than 80% * Patients with chronic obstructive pulmonary disease or asthma.
Contact & Investigator
Zeinab Helmy, Professor
STUDY CHAIR
Professor of Physical Therapy for Cardiovascular / Respiratory Disorder and Geriatrics. Faculty of Physical Therapy. Cairo University
Frequently Asked Questions
Who can join the NCT06673953 clinical trial?
This trial is open to male participants only, aged 45 Years or older, up to 55 Years, studying Post Coronary Artery Bypass Grafting. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06673953 currently recruiting?
Yes, NCT06673953 is actively recruiting participants. Contact the research team at mostafaaly.atia@gmail.com for enrollment information.
Where is the NCT06673953 trial being conducted?
This trial is being conducted at Giza, Egypt.
Who is sponsoring the NCT06673953 clinical trial?
NCT06673953 is sponsored by Cairo University. The principal investigator is Zeinab Helmy, Professor at Professor of Physical Therapy for Cardiovascular / Respiratory Disorder and Geriatrics. Faculty of Physical Therapy. Cairo University. The trial plans to enroll 60 participants.